6CM
EXAS

683 Capital Management’s Exact Sciences EXAS Stock Holding History

683 Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,800
Closed -$132K – 71
2014
Q4 		$132K Sell
4,800
-895,200
-99% -$21.8M 0.06% 56
2014
Q3 		$17.4M Hold
900,000
– – 5.95% 2
2014
Q2 		$15.3M Buy
+900,000
New +$12.4M 5.79% 3

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

683 Capital Management's EXAS Position: Q2 2014 in Review

683 Capital Management sold out of Exact Sciences (EXAS) in Q2 2014, closing a stake of 900,000 shares — an estimated $12.4M sold.

683 Capital Management first reported a position in EXAS in Q3 2013 and held it in 3 quarters. The position peaked at $12.8M in Q1 2014. 156 funds tracked by Wall St. Rank hold EXAS as of Q2 2014.

  • 683 Capital Management reported no remaining Exact Sciences position as of Q2 2014 after selling out during the quarter.
  • 683 Capital Management sold 900,000 Exact Sciences shares in Q2 2014, an estimated $12.4M.
  • 683 Capital Management first reported a position in Exact Sciences in Q3 2013 and held it in 3 quarters.
  • 683 Capital Management's Exact Sciences position peaked at $12.8M in Q1 2014.
  • 156 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2014.

Based on 683 Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.